Fig. 2

PFS estimated using the Kaplan-Meier method by number of lines of therapy used before the start of treatment with DAB/TRA (PFS analysis set). CI confidence interval, DAB dabrafenib, NE not estimable, PFS progression-free survival, TRA trametinib. Two patients were categorized as unknown/ not specified.